title: The conditioned place preference test for assessing welfare consequences and potential refinements in a mouse bladder cancer model.
abstract: Most pre-clinical analgesic efficacy assays still involve nociceptive testing in rodents. This is despite concerns as to the relevance of these tests for evaluating the pain-preventative properties of drugs. More appropriate methods would target pain rather than nociception, but these are currently not available, so it remains unknown whether animal pain equates to the negatively affective and subjective/emotional state it causes in humans. Mouse cancer models are common despite the likelihood of substantial pain. We used Conditioned Place Preference (CPP) testing, assessments of thermal hyperalgesia and behaviour to determine the likelihood that MBT-2 bladder cancer impacts negatively on mouse welfare, such as by causing pain. There was no CPP to saline, but morphine preference in tumour bearing mice exceeded that seen in tumour-free controls. This occurred up to 10 days before the study end-point alongside reduced body weight, development of hyperalgesia and behaviour changes. These effects indicated mice experienced a negative welfare state caused by malaise (if not pain) before euthanasia. Due to the complexity of the assessments needed to demonstrate this, it is unlikely that this approach could be used for routine welfare assessment on a study-by-study basis. However, our results show mice in sufficiently similar studies are likely to benefit from more intensive severity assessment and re-evaluation of end-points with a view to implementing appropriate refinements. In this particular case, a refinement would have been to have euthanased mice at least 7 days earlier or possibly by provision of end-stage pain relief. CPP testing was found to be a helpful method to investigate the responses of mice to analgesics, possibly on a subjective level. These findings and those of other recent studies show it could be a valuable method of screening candidate analgesics for efficacy against cancer pain and possibly other pain or disease models.
authors.affiliation: Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom.
authors.forename: John V
authors.initials: JV
authors.lastname: Roughan
authors.affiliation: Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom.
authors.forename: Claire A
authors.initials: CA
authors.lastname: Coulter
authors.affiliation: Comparative Biology Centre, The Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Flecknell
authors.affiliation: Northern Institute for Cancer Research, The Medical School, University of Newcastle, Newcastle upon Tyne, United Kingdom.
authors.forename: Huw D
authors.initials: HD
authors.lastname: Thomas
authors.affiliation: Research Institute of Pharmaceutical Sciences and Departments of Psychology and Pharmacology, Peabody Building, University of Mississippi, Oxford, Mississippi, United States of America.
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Sufka
mesh_terms: D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal; D004353:Drug Evaluation, Preclinical / Q000379:methods; D005260:Female; D006930:Hyperalgesia / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D009374:Neoplasms, Experimental; D010146:Pain / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology
chemical_list: D000700:Analgesics
references.citation: Pain. 2005 Sep;117(1-2):19-29
references.pmid: 16043290
references.citation: Pain. 2012 Apr;153(4):924-933
references.pmid: 22387095
references.citation: J Am Assoc Lab Anim Sci. 2012 Jan;51(1):42-9
references.pmid: 22330867
references.citation: Pain. 1999 Mar;80(1-2):67-82
references.pmid: 10204719
references.citation: Pain. 1994 Sep;58(3):355-366
references.pmid: 7838585
references.citation: Lab Anim. 2009 Jan;43(1):17-26
references.pmid: 19015177
references.citation: Neurosci Lett. 2012 Jan 17;507(1):57-61
references.pmid: 22172927
references.citation: PLoS One. 2012;7(4):e35656
references.pmid: 22558191
references.citation: Pain. 2011 Jul;152(7):1641-1648
references.pmid: 21474245
references.citation: Basic Clin Pharmacol Toxicol. 2013 Nov;113(5):325-8
references.pmid: 23773283
references.citation: Contemp Top Lab Anim Sci. 2000 Nov;39(6):18-23
references.pmid: 11487247
references.citation: PLoS One. 2013 Sep 30;8(9):e75948
references.pmid: 24098748
references.citation: Pain. 2007 Jul;130(1-2):108-18
references.pmid: 17196337
references.citation: Br J Pharmacol. 1977 Aug;60(4):547-54
references.pmid: 409449
references.citation: Pain. 1996 Jul;66(1):99-103
references.pmid: 8857636
references.citation: Behav Pharmacol. 2004 Nov;15(7):461-72
references.pmid: 15472568
references.citation: Nat Rev Neurosci. 2012 Dec;13(12):859-66
references.pmid: 23165262
references.citation: Brain Behav Immun. 2001 Sep;15(3):255-65
references.pmid: 11566049
references.citation: Lab Anim. 2012 Oct;46(4):304-10
references.pmid: 23097564
references.citation: Psychopharmacology (Berl). 2000 Dec;153(1):31-43
references.pmid: 11255927
references.citation: Br J Cancer. 1998;77(1):1-10
references.pmid: 9459138
references.citation: Pain. 2004 Jan;107(1-2):33-40
references.pmid: 14715386
references.citation: Eur J Pain. 2011 Mar;15(3):299-305
references.pmid: 20801699
references.citation: Neuroscience. 2013 Dec 3;253:172-82
references.pmid: 23988433
references.citation: J Pain. 2011 Aug;12(8):868-74
references.pmid: 21515090
references.citation: Ann Oncol. 2007 Sep;18(9):1437-49
references.pmid: 17355955
references.citation: Neurosci Biobehav Rev. 2000 May;24(3):375-89
references.pmid: 10781697
references.citation: J Pharmacol Exp Ther. 1995 Dec;275(3):1535-42
references.pmid: 8531126
references.citation: Pain. 2013 Sep;154(9):1551-1568
references.pmid: 23707265
references.citation: Pain. 2011 Sep;152(9):1942-1943
references.pmid: 21550170
references.citation: Anesth Analg. 2013 Jan;116(1):224-31
references.pmid: 23223118
references.citation: Lab Anim. 1999 Jan;33(1):16-23
references.pmid: 10759387
references.citation: Nat Methods. 2010 Jun;7(6):447-9
references.pmid: 20453868
references.citation: Pain. 2004 Jul;110(1-2):385-92
references.pmid: 15275790
references.citation: Biomed Res Int. 2013;2013:624815
references.pmid: 24073414
references.citation: Eur J Pain. 2008 Jul;12(5):582-90
references.pmid: 18023377
references.citation: Pain. 1988 Jan;32(1):77-88
references.pmid: 3340425
references.citation: Lab Anim. 2004 Jul;38(3):286-96
references.pmid: 15207040
references.citation: Pain. 2001 Feb 1;90(1-2):65-74
references.pmid: 11166971
references.citation: Res Vet Sci. 2009 Oct;87(2):336-47
references.pmid: 19303122
references.citation: Jpn J Cancer Res. 2002 Jul;93(7):729-35
references.pmid: 12149137
references.citation: Br J Cancer. 2010 May 25;102(11):1555-77
references.pmid: 20502460
references.citation: J Pharmacol Exp Ther. 1996 Oct;279(1):177-85
references.pmid: 8858991
references.citation: Lab Anim. 2009 Oct;43(4):357-61
references.pmid: 19535390
references.citation: Nat Neurosci. 2009 Nov;12(11):1364-6
references.pmid: 19783992
references.citation: J Neurosci. 2011 Oct 26;31(43):15450-4
references.pmid: 22031891
references.citation: J Urol. 1991 Jun;145(6):1297-301
references.pmid: 2033720
references.citation: Trends Pharmacol Sci. 2012 Nov;33(11):568-73
references.pmid: 22959652
references.citation: J Ethnopharmacol. 2007 Jan 19;109(2):226-8
references.pmid: 17005345
references.citation: Eur J Pain. 2003;7(5):397-406
references.pmid: 12935791
references.citation: Science. 1973 Aug 10;181(4099):576-8
references.pmid: 4721056
references.citation: Lab Anim. 1993 Oct;27(4):374-80
references.pmid: 8277712
references.citation: Eur J Pharmacol. 2002 Apr 26;441(3):185-91
references.pmid: 12063091
references.citation: Handb Clin Neurol. 2006;81:325-41
references.pmid: 18808845
references.citation: Brain Behav Immun. 2007 Aug;21(6):767-74
references.pmid: 17291715
references.citation: Res Vet Sci. 2000 Dec;69(3):283-8
references.pmid: 11124101
references.citation: J Pharmacol Pharmacother. 2010 Jul;1(2):94-9
references.pmid: 21350617
references.citation: J Pharmacol Sci. 2003 Feb;91(2):167-70
references.pmid: 12686763
references.citation: Neuroscience. 2008 Nov 11;157(1):12-21
references.pmid: 18804517
references.citation: Pain. 2011 May;152(5):990-1000
references.pmid: 21256675
references.citation: Yonsei Med J. 2005 Apr 30;46(2):252-9
references.pmid: 15861499
references.citation: J Pain. 2006 Jun;7(6):408-16
references.pmid: 16750797
references.citation: Br Vet J. 1993 Nov-Dec;149(6):515-25
references.pmid: 8111612
references.citation: Pain. 2011 May;152(5):963-964
references.pmid: 21292396
references.citation: Pharmacol Biochem Behav. 2004 Oct;79(2):243-51
references.pmid: 15501299
references.citation: Pain. 2004 Nov;112(1-2):12-5
references.pmid: 15494180
references.citation: Brain Res Brain Res Protoc. 2004 Aug;13(3):151-8
references.pmid: 15296852